10 Cheap Robotics Stocks To Buy
The progress of Western civilization is built on industrialization.
Posts Tagged ‘NASDAQ:ILMN’
Shake-Up Alert: 40 Companies Facing Activist Pressure
The equity market has been on a roll, rallying by 10% in the first half of 2024, adding to the 24% gain registered in 2024.
Illumina, Inc. (NASDAQ:ILMN) Q2 2024 Earnings Call Transcript
Operator: Good day ladies and gentlemen and welcome to the Second Quarter 2024 Illumina Earnings Conference Call. At this time, all participants are in a listen-only mode.
Here’s Why You Should Add Illumina (ILMN) to Your Portfolio
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” second quarter 2024 investor letter. A copy of the letter can...
Should You Consider Adding Illumina (ILMN) to Your Portfolio?
Ensemble Capital Management, an investment management company, released its second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Illumina, Inc. (NASDAQ:ILMN) Q1 2024 Earnings Call Transcript
Illumina, Inc. misses on earnings expectations. Reported EPS is $-0.79245 EPS, expectations were $0.03. Illumina, Inc.
14 Best Medical Device Stocks To Buy Now
In this article, we will discuss the 14 Best Medical Device Stocks To Buy Now.
Hedge Funds and Insiders Are Buying These 5 Stocks
This article presents an overview of Hedge Funds and Insiders Are Buying These 5 Stocks. For a detailed overview of such stocks, read our article, Hedge Funds and Insiders ...
10 Biggest Stocks Targeted By Activist Investors Right Now
In this article, we're going to take a look at 10 biggest stocks targeted by activist investors right now.
Reasons for the Decline of Illumina (ILMN)
Baron Funds, an investment management company, released its “Baron Opportunity Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
Do You Believe in the Growth Prospects of Illumina (ILMN)?
RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark Large Growth Fund” fourth quarter 2023 investor...
Illumina, Inc. (NASDAQ:ILMN) Q4 2023 Earnings Call Transcript
Illumina, Inc. beats earnings expectations. Reported EPS is $0.14, expectations were $0.01. Illumina, Inc.
Jim Cramer is Bearish on These 5 Stocks
This article presents an overview of Jim Cramer is Bearish on These 5 Stocks. For a detailed overview of such stocks, read our article Jim Cramer is Bearish on These 12 Stocks...
Illumina (ILMN) Leads the Market With 80% Share
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter 2023 investor letter.
Here’s Why Polen Focus Growth Sold Illumina (ILMN)
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” fourth quarter 2023 investor letter.
Here’s How the New AI Algorithm Helps Illumina (ILMN)
Ensemble Capital Management, an investment management company, released its fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
5 Best Genomics Stocks To Buy Now
In this piece, we will take a look at the five best genomics stocks to buy now.
12 Best Medical Technology Stocks To Buy Now
In this article, we discuss 12 of the best medical device stocks to buy now.
Weaker Guidance Dragged Illumina (ILMN) in Q3
RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark Large Growth Fund” third quarter 2023 investor...
Worried About Deficit Stan Druckenmiller Is Still Very Bullish On These Stocks
In this article, we discuss worried about the deficit Stan Druckenmiller is still very bullish on these stocks.
Illumina, Inc. (NASDAQ:ILMN) Q3 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the Third Quarter 2023 Illumina Earnings Conference Call. At this time, all participants are in a listen-only mode.
Several Reasons Hampered Illumina (ILMN) in Q3
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” third-quarter 2023 investor letter. A copy of the same can be downloaded here.
Here’s Why Illumina (ILMN) Declined in Q3
Ensemble Capital Management, an investment management company, released its third quarter 2023 investor letter. A copy of the same can be downloaded here.
11 Best Long-Term Stocks To Buy For High Returns
In this piece, we will take a look at the 11 best long term stocks to buy for high returns.
Top 5 Genomics Companies in the World
In this piece, we will take a look at the top five genomics companies in the world.
11 Best Immunotherapy Stocks To Buy Now
In this article, we discuss 11 of the best immunotherapy stocks to buy now.
Top 30 Oncology Companies in the World
In this article, we shall cover the top 30 oncology companies in the world.
14 Best Cancer Stocks To Buy Now
In this article, we discuss 14 best cancer stocks to buy.
14 Best Depressed Stocks To Buy Now
Legendary value investor Howard Marks started writing memos to investors decades ago.
15 Recent Activist Investor Campaigns
It's never a dull day in the markets with activist investors deploying all kinds of strategies in the race to unlock and maximize hidden value in highly undervalued stocks.
13 Best Beaten Down Stocks To Buy Now
In this article, we will be taking a look at the 13 best beaten down stocks to buy now.
Should You Hold Illumina (ILMN)?
RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark Large Growth Fund” second quarter 2023 investor...
Here’s Why Illumina (ILMN) Declined in Q2
Baron Funds, an investment management company, released its “Baron Fifth Avenue Growth Fund” second quarter 2023 investor letter.
Illumina, Inc. (NASDAQ:ILMN) Q2 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the Second Quarter 2023 Illumina Earnings Conference Call. At this time, all participants are in a listen-only mode.
Acquisition of Grail Pressured Illumina (ILMN)’s Stock Price
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” second-quarter 2023 investor letter.
Here’s Why Illumina (ILMN) Declined -19.4% in Q2
Ensemble Capital Management, an investment management company, released its second quarter 2023 investor letter. A copy of the same can be downloaded here.
10 Personalized Medicine Stocks Billionaires Are Loading Up On
In this article, we will take a look at the 10 personalized medicine stocks billionaires are purchasing.
5 DNA Stocks Billionaires Are Loading Up On
In this article, we discuss 5 DNA stocks that billionaires love.
Here’s Why Baron Partners Fund Exited Illumina (ILMN)
Baron Funds, an investment management company, released its “Baron Partners Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.
15 Best Stocks to Buy and Hold According to Billionaire Carl Icahn
In this article, we discuss 15 best stocks to buy and hold according to billionaire Carl Icahn.
Illumina, Inc. (NASDAQ:ILMN) Q1 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the First Quarter 2023 Illumina Earnings Conference Call. At this time, all participants are in a listen-only mode.
11 Most Promising Cancer Stocks According to Analysts
In this article, we discuss 11 most promising cancer stocks according to analysts.
Illumina, Inc. (NASDAQ:ILMN) Q4 2022 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the Fourth Quarter 2022 Illumina Earnings Conference Call. .
Top 25 Smartest Companies To Buy According To Hedge Funds
In this piece, we will take a look at the top 25 smartest companies to buy according to hedge funds.
Analysts Are Cutting Price Targets of These 10 Stocks
In this article, we will discuss the 10 stocks whose price targets were recently trimmed by analysts.
Should You Hold Illumina (ILMN)?
Ensemble Capital Management, an investment management company, released its 2022 annual investor letter. A copy of the same can be downloaded here.
12 Blue Chip Stocks to Buy That Are Down Over 30% YTD
In this article, we take a look at 12 blue chip stocks to buy that are down over 30% YTD.
5 Best Genomics Stocks To Buy Now
Agilent Technologies, Inc. (NYSE:A) provides application-focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
5 Best Biotech Stocks To Buy According To Hedge Funds
In this article, we discuss 5 best biotech stocks to buy according to hedge funds.
Alphabet Inc (GOOGL) Investment Portfolio: Top 15 Companies
In this article, we discuss the top 15 companies in Alphabet Inc (GOOGL)’s investment portfolio.
